{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T10:34:58Z","timestamp":1793270098359,"version":"4.5.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:00:00Z","timestamp":1786665600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastroenterolog\u00eda y Hepatolog\u00eda"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.gastrohep.2026.502841","type":"journal-article","created":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T23:25:16Z","timestamp":1786749916000},"page":"502841","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Liver tumors in anabolic steroid users: A practical approach for the gastroenterologist and hepatologist"],"prefix":"10.1016","volume":"49","author":[{"given":"Enrico","family":"Fulco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Stingo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giancarlo","family":"Orlando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.gastrohep.2026.502841_bib0130","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.1059473","article-title":"Anabolic-androgenic steroids: how do they work and what are the risks?","volume":"13","author":"Bond","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.gastrohep.2026.502841_bib0135","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1111\/bph.14995","article-title":"Anabolic androgenic steroid abuse in the United Kingdom: an update","volume":"177","author":"Mullen","year":"2020","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.gastrohep.2026.502841_bib0140","doi-asserted-by":"crossref","DOI":"10.2174\/0102506882253706240104073440","article-title":"Anabolic androgenic steroids: a review","volume":"5","author":"Rohilla","year":"2024","journal-title":"New Emirat Med J"},{"key":"10.1016\/j.gastrohep.2026.502841_bib0145","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1210\/jc.2018-00229","article-title":"Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline","volume":"103","author":"Bhasin","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.gastrohep.2026.502841_bib0150","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1249\/JSR.0000000000000467","article-title":"Anabolic steroid effect on the liver","volume":"17","author":"Niedfeldt","year":"2018","journal-title":"Curr Sports Med Rep"},{"key":"10.1016\/j.gastrohep.2026.502841_bib0155","doi-asserted-by":"crossref","first-page":"599","DOI":"10.3390\/gastroent15030044","article-title":"Anabolic androgenic steroids and hepatocellular adenoma and carcinoma: molecular mechanisms and clinical implications","volume":"15","author":"Ielasi","year":"2024","journal-title":"Gastroenterol Insights"},{"key":"10.1016\/j.gastrohep.2026.502841_bib0160","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.3748\/wjg.v28.i26.3071","article-title":"Anabolic androgenic steroid-induced liver injury: an update","volume":"28","author":"Petrovic","year":"2022","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.gastrohep.2026.502841_bib0165","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"issue":"S1","key":"10.1016\/j.gastrohep.2026.502841_bib0170","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/hep.31288","article-title":"Epidemiology of hepatocellular carcinoma","volume":"73","author":"McGlynn","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.gastrohep.2026.502841_bib0175","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/j.1478-3231.2010.02346.x","article-title":"Anabolic-androgenic steroids: a possible new risk factor of toxicant-associated fatty liver disease","volume":"31","author":"Schwingel","year":"2011","journal-title":"Liver Int"},{"key":"10.1016\/j.gastrohep.2026.502841_bib0180","doi-asserted-by":"crossref","first-page":"e27","DOI":"10.1136\/bjsm.2004.013599","article-title":"Hepatocellular adenomas associated with anabolic androgenic steroid abuse in bodybuilders: a report of two cases and a review of the literature","volume":"39","author":"Socas","year":"2005","journal-title":"Br J Sports Med"},{"key":"10.1016\/j.gastrohep.2026.502841_bib0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.beem.2022.101665","article-title":"Basics of androgen synthesis and action","volume":"36","author":"Naamneh Elzenaty","year":"2022","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.gastrohep.2026.502841_bib0190","doi-asserted-by":"crossref","first-page":"13768","DOI":"10.3390\/ijms232213768","article-title":"Constitutively active androgen receptor in hepatocellular carcinoma","volume":"23","author":"Montgomery","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.gastrohep.2026.502841_bib0195","doi-asserted-by":"crossref","first-page":"3159","DOI":"10.1172\/JCI45967","article-title":"Cell cycle-related kinase is a direct androgen receptor-regulated gene that drives beta-catenin\/T cell factor-dependent hepatocarcinogenesis","volume":"121","author":"Feng","year":"2011","journal-title":"J Clin Invest"},{"key":"10.1016\/j.gastrohep.2026.502841_bib0200","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1002\/hep.32120","article-title":"Phosphorylation of androgen receptor by mTORC1 promotes liver steatosis and tumorigenesis","volume":"75","author":"Ren","year":"2022","journal-title":"Hepatology"},{"key":"10.1016\/j.gastrohep.2026.502841_bib0205","doi-asserted-by":"crossref","first-page":"491","DOI":"10.3390\/cancers12020491","article-title":"Molecular signaling pathways and therapeutic targets in hepatocellular carcinoma","volume":"12","author":"Dimri","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.gastrohep.2026.502841_bib0210","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1002\/hep.22833","article-title":"virus X protein enhances the transcriptional activity of the androgen receptor through c-Src and glycogen synthase kinase-3beta kinase pathways","volume":"49","author":"Yang","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.gastrohep.2026.502841_bib0215","doi-asserted-by":"crossref","first-page":"11066","DOI":"10.1128\/JVI.01300-08","article-title":"Hepatitis C virus core protein augments androgen receptor-mediated signaling","volume":"82","author":"Kanda","year":"2008","journal-title":"J Virol"},{"key":"10.1016\/j.gastrohep.2026.502841_bib0220","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/j.jhep.2017.07.009","article-title":"Molecular classification of hepatocellular adenoma in clinical practice","volume":"67","author":"Nault","year":"2017","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastrohep.2026.502841_bib0225","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/hep.21068","article-title":"Genotype-phenotype correlation in hepatocellular adenoma: new classification and relationship with HCC","volume":"43","author":"Zucman-Rossi","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.gastrohep.2026.502841_bib0230","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1093\/bjr\/tqae180","article-title":"Hepatocellular adenoma update: diagnosis, molecular classification, and clinical course","volume":"97","author":"Poetter-Lang","year":"2024","journal-title":"Br J Radiol"},{"key":"10.1016\/j.gastrohep.2026.502841_bib0235","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.crad.2016.12.020","article-title":"Hepatocellular adenoma: imaging review of the various molecular subtypes","volume":"72","author":"Dharmana","year":"2017","journal-title":"Clin Radiol"},{"key":"10.1016\/j.gastrohep.2026.502841_bib0240","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.jhep.2016.04.001","article-title":"EASL Clinical Practice Guidelines on the management of benign liver tumours","volume":"65","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastrohep.2026.502841_bib0245","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1016\/j.dld.2022.08.031","article-title":"Benign liver lesions 2022: Guideline for clinical practice of the Associazione Italiana Studio del Fegato and collaborating societies \u2013 Part II \u2013 solid lesions","volume":"54","author":"Pompili","year":"2022","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.gastrohep.2026.502841_bib0250","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.14309\/ajg.0000000000002857","article-title":"ACG clinical guideline: focal liver lesions","volume":"119","author":"Frenette","year":"2024","journal-title":"Am J Gastroenterol"}],"container-title":["Gastroenterolog\u00eda y Hepatolog\u00eda"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0210570526009301?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0210570526009301?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T09:54:51Z","timestamp":1793267691000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0210570526009301"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":25,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S0210570526009301"],"URL":"https:\/\/doi.org\/10.1016\/j.gastrohep.2026.502841","relation":{},"ISSN":["0210-5705"],"issn-type":[{"value":"0210-5705","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Liver tumors in anabolic steroid users: A practical approach for the gastroenterologist and hepatologist","name":"articletitle","label":"Article Title"},{"value":"Gastroenterolog\u00eda y Hepatolog\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gastrohep.2026.502841","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"502841"}}